Opko Health Revenue and Competitors
Estimated Revenue & Valuation
- Opko Health's estimated annual revenue is currently $1.9B per year.
- Opko Health's estimated revenue per employee is $666,192
- Opko Health's total funding is $206M.
- Opko Health's current valuation is $3.1B. (January 2022)
Employee Data
- Opko Health has 2807 Employees.
- Opko Health grew their employee count by 3% last year.
Opko Health's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO EirGen Pharma | Reveal Email/Phone |
2 | Executive Assistant, Dr. J. Hsiao, Ph. D., V. Chairman the Board Dr. C. Bishop, CEO Renal Div. | Reveal Email/Phone |
3 | CEO & Chairman | Reveal Email/Phone |
4 | CEO, Renal Division | Reveal Email/Phone |
5 | SVP & CFO | Reveal Email/Phone |
6 | VP Finance | Reveal Email/Phone |
7 | EVP | Reveal Email/Phone |
8 | Head Human Resources | Reveal Email/Phone |
9 | VP Information Technology | Reveal Email/Phone |
10 | vice chairman | Reveal Email/Phone |
Opko Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $31800M | 109578 | 4% | $367M | $146B |
What Is Opko Health?
OPKO Health is a healthcare company focusing on the commercialization and development of proprietary pharmaceuticals and instruments for the diagnosis and treatment of ophthalmologic disorders. Although organic growth is of paramount interest to us, we will be opportunistic in acquiring operating businesses, particularly to expand into international markets.
keywords:N/A$206M
Total Funding
2807
Number of Employees
$1.9B
Revenue (est)
3%
Employee Growth %
$3.1B
Valuation
N/A
Accelerator
Opko Health News
Shares of OPKO Health, Inc. (NASDAQ:OPK Get Rating) have received a consensus recommendation of Hold from the six brokerages that are...
OPKO Health, Inc. (NASDAQ:OPK) is a healthcare company focusing on pharmaceuticals and diagnostic tests. The company is publicly traded on...
OPKO Health, Inc. (NASDAQ:OPK) is in the diagnostics and pharmaceutical business internationally. The stock has disappointed us for a long...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $632.3M | 2948 | 12% | $1.5B |
#2 | $638.2M | 3188 | 10% | $124.5M |
#3 | $1146.2M | 3236 | 5% | N/A |
#4 | $15M | 3565 | 48% | N/A |
#5 | $825.9M | 3933 | 39% | N/A |